Other studies have shown that increased VCAN is correlated with elevated prostate-specific antigen levels and poorer prognosis in prostate cancer, including an increased risk of metastasis following radical prostatectomy [14,15]. This evidence concerns the gene VCAN and prostate carcinoma.